Trial Profile
Phase I trial of single agent SGT-RB94 for the treatment of patients with previously treated metastatic cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs SGT-94 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man
- 12 May 2016 New trial record
- 20 Apr 2016 Results presented at the 107th Annual Meeting of the American Association for Cancer Research